AXOVIA Transparent Background_Color.png
Renowned Geneticist Philip Beales Launches Axovia Therapeutics to Develop Transformative Medicines for Ciliopathies
25 févr. 2021 07h00 HE | Axovia Therapeutics
Axovia is focused on developing transformative gene therapies for cilia disorders, starting with Bardet-Biedl SyndromeAxovia is a majority-owned subsidiary of Jaguar Gene Therapy, which is backed by...